With health experts around the world warning about the dangers of blood clots from Yaz and Yasmin birth control in recent years, many thought the message was clearly out.
However, earlier this month, regulators in the United Kingdom surprised many when they ordered doctors to issue a fresh Yaz warning to millions of women.
The move comes as thousands of lawsuits in the United States continue to move through the courts and the maker of Yaz and Yasmin, Bayer, has paid billions in settlements to those injured.
Previously, the FDA, Health Canada, EMA, New England Journal of Medicine and British Medical Journal had all published warnings that the progestin hormone drospirenone, used in Yaz and Yasmin, could increase the rate of blood clots.
The FDA has received over 20,000 reports of women who took the pills suffering blood clot injuries such as stroke, deep vein thrombosis (DVT) or pulmonary embolism.
Now, The U.K.’s Medicines and Healthcare Products Regulatory Agency (MHRA) has ordered all general practitioner doctors to warn women taking birth control like Yasmin that they may be twice as likely to develop blood clots.
While many have hear the blood clot warnings for Yaz and Yasmin, most still don’t know that Bayer is paying settlements to those affected. As of their last financial report, they had paid over $1.6 billion to settle more than 7,600 cases, an average of more than $200,000 per case.
The latest report, due out Friday, will give updated settlement figures that many expect to be near $2 billion. And, the settlements are expected to last through 2014 as long as a patient’s case qualifies.
If you or a family member experienced a blood clot, stroke, DVT or pulmonary embolism while using Yaz or Yasmin, it is important to learn whether you qualify for a settlement. Contact us today for more information or to speak with a lawyer.
It costs nothing to discuss your case or file a claim. Due to the complexity of these cases, however, DrugRisk only recommends lawyers who have already settled hundreds of Yaz lawsuits.